$ADXN Addex Therapeutics Ltd ADR NASDAQ:ADXN Addex Therapeutics Ltd ADR
entry PT 5
Target PTs 9 --> 12 --> 20 and higher
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. T